Disease · HP_0002018
Comparisons in its trials33
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 33
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| NP101 Patch vs Placebo Patch: serious adverse events | 0 of 234 | 0 of 235 | 469 | NCT00724815 | Trial comparisons |
| NP101 Patch vs Placebo Patch: Photophobia Free at Two Hours | 116 of 226 | 83 of 228 | 454 | NCT00724815 | Trial comparisons |
| NP101 Patch vs Placebo Patch: Pain Free at Two Hours | 40 of 226 | 21 of 228 | 454 | NCT00724815 | Trial comparisons |
| NP101 Patch vs Placebo Patch: Nausea Free at Two Hours | 189 of 226 | 144 of 228 | 454 | NCT00724815 | Trial comparisons |
| NP101 Patch vs Placebo Patch: Phonophobia Free at Two Hours | 125 of 226 | 89 of 228 | 454 | NCT00724815 | Trial comparisons |
| Ginger vs Placebo: Occurrence of Intra-operative and Post-operative Vomiting | 30 of 116 | 45 of 123 | 239 | NCT01733212 | Trial comparisons |
| Ginger vs Placebo: deaths from any cause | 0 of 116 | 0 of 123 | 239 | NCT01733212 | Trial comparisons |
| Ginger vs Placebo: serious adverse events | 0 of 116 | 0 of 123 | 239 | NCT01733212 | Trial comparisons |
| Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Objective Response Rate | 65 of 115 | 66 of 115 | 230 | NCT01718873 | Trial comparisons |
| Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: deaths from any cause | 2 of 115 | 2 of 115 | 230 | NCT01718873 | Trial comparisons |
| Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Disease Control Rate | 107 of 115 | 103 of 115 | 230 | NCT01718873 | Trial comparisons |
| Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: serious adverse events | 65 of 115 | 75 of 115 | 230 | NCT01718873 | Trial comparisons |
| Bevacizumab Before Chemotherapy vs Bevacizumab With Chemotherapy: Toxic Effects | 108 of 114 | 113 of 115 | 229 | NCT01718873 | Trial comparisons |
| Ketorolac Group vs IV Meloxicam Group: Length of Stay as Measured by Same Day Discharges | 23 of 114 | 10 of 109 | 223 | NCT05291598 | Trial comparisons |
| Ketorolac Group vs IV Meloxicam Group: deaths from any cause | 0 of 114 | 0 of 109 | 223 | NCT05291598 | Trial comparisons |
| Ketorolac Group vs IV Meloxicam Group: serious adverse events | 0 of 114 | 0 of 109 | 223 | NCT05291598 | Trial comparisons |
| Intrathecal Hydromorphone vs Intrathecal Morphine: Nausea | 28 of 66 | 32 of 68 | 134 | NCT02789410 | Trial comparisons |
| Intrathecal Hydromorphone vs Intrathecal Morphine: deaths from any cause | 0 of 66 | 0 of 68 | 134 | NCT02789410 | Trial comparisons |
| Intrathecal Hydromorphone vs Intrathecal Morphine: Pruritus | 27 of 66 | 28 of 68 | 134 | NCT02789410 | Trial comparisons |
| Intrathecal Hydromorphone vs Intrathecal Morphine: serious adverse events | 0 of 66 | 0 of 68 | 134 | NCT02789410 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0002018/comparisons